SG11201401188QA - Method for producing megakaryocytes and/or platelets from pluripotent stem cells - Google Patents

Method for producing megakaryocytes and/or platelets from pluripotent stem cells

Info

Publication number
SG11201401188QA
SG11201401188QA SG11201401188QA SG11201401188QA SG11201401188QA SG 11201401188Q A SG11201401188Q A SG 11201401188QA SG 11201401188Q A SG11201401188Q A SG 11201401188QA SG 11201401188Q A SG11201401188Q A SG 11201401188QA SG 11201401188Q A SG11201401188Q A SG 11201401188QA
Authority
SG
Singapore
Prior art keywords
platelets
stem cells
pluripotent stem
producing megakaryocytes
megakaryocytes
Prior art date
Application number
SG11201401188QA
Other languages
English (en)
Inventor
Taito Nishino
Takanori Nakamura
Shunsuke Iwamoto
Koji Eto
Hiromitsu Nakauchi
Kayoko Tsuji
Original Assignee
Nissan Chemical Ind Ltd
Univ Tokyo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nissan Chemical Ind Ltd, Univ Tokyo filed Critical Nissan Chemical Ind Ltd
Publication of SG11201401188QA publication Critical patent/SG11201401188QA/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0644—Platelets; Megakaryocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/15—Cells of the myeloid line, e.g. granulocytes, basophils, eosinophils, neutrophils, leucocytes, monocytes, macrophages or mast cells; Myeloid precursor cells; Antigen-presenting cells, e.g. dendritic cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/19—Platelets; Megacaryocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/38—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D333/40—Thiophene-2-carboxylic acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/38—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/145—Thrombopoietin [TPO]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/165—Vascular endothelial growth factor [VEGF]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/70—Enzymes
    • C12N2501/73—Hydrolases (EC 3.)
    • C12N2501/734—Proteases (EC 3.4.)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/999—Small molecules not provided for elsewhere
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2502/00—Coculture with; Conditioned medium produced by
    • C12N2502/13—Coculture with; Conditioned medium produced by connective tissue cells; generic mesenchyme cells, e.g. so-called "embryonic fibroblasts"
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
    • C12N2506/02—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from embryonic cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
    • C12N2506/45—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from artificially induced pluripotent stem cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Developmental Biology & Embryology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Medicinal Preparation (AREA)
SG11201401188QA 2011-10-03 2012-10-03 Method for producing megakaryocytes and/or platelets from pluripotent stem cells SG11201401188QA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2011219545 2011-10-03
PCT/JP2012/075705 WO2013051625A1 (ja) 2011-10-03 2012-10-03 多能性幹細胞からの巨核球及び／又は血小板の製造方法

Publications (1)

Publication Number Publication Date
SG11201401188QA true SG11201401188QA (en) 2014-09-26

Family

ID=48043779

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201401188QA SG11201401188QA (en) 2011-10-03 2012-10-03 Method for producing megakaryocytes and/or platelets from pluripotent stem cells

Country Status (7)

Country Link
US (1) US20140227780A1 (ru)
EP (1) EP2765187B1 (ru)
JP (2) JP5876498B2 (ru)
KR (1) KR102031386B1 (ru)
RU (1) RU2014117642A (ru)
SG (1) SG11201401188QA (ru)
WO (1) WO2013051625A1 (ru)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201210857D0 (en) 2012-06-19 2012-08-01 Cambridge Entpr Ltd Transcription factor mediated programming towards megakaryocytes
CA2896053A1 (en) 2012-12-21 2014-06-26 Ocata Therapeutics, Inc. Methods for production of platelets from pluripotent stem cells and compositions thereof
JP6551963B2 (ja) * 2014-05-14 2019-07-31 国立大学法人京都大学 巨核球前駆細胞の製造方法
SG11201703407UA (en) * 2014-10-31 2017-05-30 Nissan Chemical Ind Ltd Ligand-binding fiber and cell culture substrate using said fiber
RU2750740C2 (ru) * 2015-03-09 2021-07-02 Мегакарион Корпорейшн Способ получения культуры, содержащей мегакариоциты, и способ получения тромбоцитов с ее применением
JP6903866B2 (ja) * 2016-01-27 2021-07-14 国立大学法人 熊本大学 血液由来単球の増殖誘導方法
JP7350246B2 (ja) 2016-01-29 2023-09-26 国立大学法人京都大学 血小板産生促進剤のスクリーニング方法
WO2018027114A1 (en) * 2016-08-04 2018-02-08 Icahn School Of Medicine At Mount Sinai Production of megakaryoctye compositions and therapies for treatment of thrombocytopenia
US11473057B2 (en) * 2016-09-02 2022-10-18 Takara Bio Inc. Method for obtaining microglia from pluripotent stem cells
US10607094B2 (en) 2017-02-06 2020-03-31 Magna Electronics Inc. Vehicle vision system with traffic sign recognition
BR112020013656A2 (pt) 2018-01-05 2020-12-01 Platelet Biogenesis, Inc. composições e métodos para produção de megacariócitos
CN112805268A (zh) * 2018-09-28 2021-05-14 日产化学株式会社 用于促进旁分泌因子的产生的培养基添加试剂

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3655123A (en) * 1966-08-08 1972-04-11 Us Health Education & Welfare Continuous flow blood separator
UA82695C2 (ru) * 2003-06-06 2008-05-12 Нисан Кемикал Индастриз, Лтд. Гетероароматические соединения как активаторы рецептора тромбопоэтина
US20050130302A1 (en) * 2003-09-29 2005-06-16 Reprocell Inc. Method and composition for regulating expansion of stem cells
US20050221482A1 (en) * 2004-03-31 2005-10-06 Burt Richard K Methods and compositions for obtaining hematopoietic stem cells derived from embryonic stem cells and uses thereof
TWI399368B (zh) * 2004-12-14 2013-06-21 Nissan Chemical Ind Ltd Amide compounds and thrombopoietin receptor activators
EP1904472A1 (en) 2005-07-15 2008-04-02 Nissan Chemical Industries, Ltd. Thiophene compounds and thrombopoietin receptor activators
EP2025671A4 (en) * 2006-06-07 2011-04-06 Nissan Chemical Ind Ltd NITROGENIC HETEROCYCLIC COMPOUND AND THROMBOPOIETIN RECEPTOR ACTIVATOR
US8058064B2 (en) * 2006-10-04 2011-11-15 The University Of Tokyo Sac-like structure enclosing hematopoietic progenitor cells produced from ES cells and method for preparing blood cells
WO2009072626A1 (ja) 2007-12-05 2009-06-11 Nissan Chemical Industries, Ltd. ヘテロ環化合物による造血幹細胞の増幅方法
JP5573160B2 (ja) 2007-12-05 2014-08-20 日産化学工業株式会社 ヘテロ環化合物による造血幹細胞の増幅方法
JP5573159B2 (ja) 2007-12-05 2014-08-20 日産化学工業株式会社 ヘテロ環化合物による造血幹細胞の増幅方法
EP2218716B1 (en) * 2007-12-06 2016-11-16 Nissan Chemical Industries, Ltd. Method for amplifying hematopoietic stem cells using heterocyclic compound
JP5858393B2 (ja) 2008-02-01 2016-02-10 国立大学法人神戸大学 抗体の可変領域を用いた新規な遺伝子発現調節方法
CN101981181B (zh) 2008-04-01 2013-05-29 国立大学法人东京大学 由iPS细胞制备血小板的方法
US8137970B2 (en) * 2008-06-30 2012-03-20 Ewha University-Industry Collaboration Foundation Methods for inducing the differentiation of hematopoietic stem cells into megakaryocytes and platelets, and gene controlling the differentiation
WO2010011644A2 (en) * 2008-07-21 2010-01-28 Taiga Biotechnologies, Inc. Differentiated anucleated cells and method for preparing the same
CA2697621C (en) * 2008-07-30 2017-01-17 Kyoto University Method of efficiently establishing induced pluripotent stem cells
CN102388130B (zh) * 2009-02-27 2014-08-27 细胞动力国际有限公司 多能细胞的分化
JP5737177B2 (ja) 2009-06-04 2015-06-17 日産化学工業株式会社 ヘテロ環化合物及び造血幹細胞の増幅剤
KR101834687B1 (ko) * 2009-09-15 2018-03-05 고쿠리츠다이가쿠호우진 도쿄다이가쿠 분화 세포의 신규 제조법
EP2490701B9 (en) * 2009-10-19 2017-11-15 Cellular Dynamics International, Inc. Cardiomyocyte production
EP2492262B1 (en) * 2009-10-23 2016-04-20 Nissan Chemical Industries, Ltd. Fused heterocyclic compound and thrombopoietin receptor activator
US9212348B2 (en) * 2010-12-01 2015-12-15 Nissan Chemical Industries, Ltd. Method for producing hematopoietic stem cells using pyrazole compounds

Also Published As

Publication number Publication date
KR102031386B1 (ko) 2019-10-11
US20140227780A1 (en) 2014-08-14
RU2014117642A (ru) 2015-11-10
WO2013051625A1 (ja) 2013-04-11
JPWO2013051625A1 (ja) 2015-03-30
EP2765187A1 (en) 2014-08-13
EP2765187B1 (en) 2018-08-08
JP5876498B2 (ja) 2016-03-02
KR20140082673A (ko) 2014-07-02
EP2765187A4 (en) 2015-04-22
JP2016005474A (ja) 2016-01-14

Similar Documents

Publication Publication Date Title
HK1217917A1 (zh) 由多能幹細胞製備血小板的方法及其組合物
ZA201708538B (en) Methods for purifying cells derived from pluripotent stem cells
SG11201401188QA (en) Method for producing megakaryocytes and/or platelets from pluripotent stem cells
IL229382B (en) A method to generate polyploid megakaryocytes and platelets
EP2861612A4 (en) METHODS FOR PREPARING PLURIPOTENT STEM CELLS
EP2686420A4 (en) PRODUCTION OF MEGACARYOCYTES AND PLAQUETTES FROM STEM CELLS
SG10201802390XA (en) Methods of differentiating stem cells into one or more cell lineages
EP2671945A4 (en) METHOD OF BREEDING HUMAN PLURIPOTENTER STEM CELLS
IL227919A0 (en) Methods and preparations for the production of stem cells related to highly active nerve cells specific to the patient
EP2904103A4 (en) PROCESS FOR THE PREPARATION OF INDUCED PLURIPOTENT STEM CELLS AND APPLICATIONS THEREOF
GB201110042D0 (en) Growth of cells
EP2900808A4 (en) METHOD FOR DIFFERENTIATING STEM CELLS IN CHONDROCYTES
EP2788770A4 (en) DOUBLE-SIDED CHROMOSOMES CONTAINING MDM2 AND ASSOCIATED METHODS
EP2912166A4 (en) METHOD FOR THE PRODUCTION OF PLURIPOTENTIAL STEM CELLS FROM CHONDROCYTES
IL226617B (en) Insulin-producing cells derived from pluripotent stem cells
GB2504996A8 (en) Stem cell culture method
EP2913396A4 (en) METHOD FOR PRODUCING DIFFERENTIATED PLURIPOTENTER STEM CELLS
EP2832850A4 (en) METHOD FOR PRODUCING PLURIPOTENTAL STRAIN CELLS FROM TOOTH CELLS
GB2520899B (en) Method for discriminating differentiation degree of pluripotent stem cell
ZA201504388B (en) Method for culturing pluripotent stem cells
SG11201406622UA (en) An in vitro method for culturing stem cells
EP2686418A4 (en) METHOD FOR THE PRODUCTION OF PLURIPOTENTAL STEM CELLS
EP2670245A4 (en) ALPHA-CÉTOHÉTÉROCYCLES AND METHODS OF MAKING AND USING THEM
EP2559757A4 (en) PROCESS FOR THE PRODUCTION OF INDUCED PLURIPOTENT STEM CELLS
IL232225A0 (en) Means and methods for growing the animals of rod-shaped bacteria